Invention Grant
![Substituted imidazo[1,2-A]pyridin-2-ylamine compounds, and pharmaceutical compositions and methods of use thereof](/docs/US/2020-08-04/US10730875B2/abs.jpg.600x600.jpg)
- Patent Title: Substituted imidazo[1,2-A]pyridin-2-ylamine compounds, and pharmaceutical compositions and methods of use thereof
-
Application No.: US16425761Application Date: 2019-05-29
-
Publication No.: US10730875B2Publication Date: 2020-08-04
- Inventor: Jin Li , Shung Wu , Minmin Yang , Sean Chen , Wenshan Hao
- Applicant: JN Therapeutics
- Applicant Address: CN Nanjing
- Assignee: JN Therapeutics
- Current Assignee: JN Therapeutics
- Current Assignee Address: CN Nanjing
- Agency: Jones Day
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K31/437 ; A61K45/06 ; C07D487/04 ; A61K47/38 ; A61K9/00 ; A61K9/10 ; A61K47/10 ; A61K31/4545 ; A61K31/496 ; A61K31/5377 ; A61K31/541
![Substituted imidazo[1,2-A]pyridin-2-ylamine compounds, and pharmaceutical compositions and methods of use thereof](/abs-image/US/2020/08/04/US10730875B2/abs.jpg.150x150.jpg)
Abstract:
Provided herein are substituted imidazo[1,2-a]pyridin-2-ylamine compounds, for example, of formula (A), and pharmaceutical compositions thereof; and methods of their use for treating, preventing, or ameliorating one or more symptoms of a Janus kinase-mediated disease.
Public/Granted literature
Information query
